Clinical Trials Browser

Urinary Bladder Neoplasms, Carcinoma, Non-Small-Cell Lung, Head and Neck Neoplasms, Kidney Neoplasms, Liver Neoplasms, Melanoma, Neoplasms, Skin Neoplasms, Colorectal Neoplasms, Endometrial Neoplasms, Triple Negative Breast Neoplasms

NCT05874726 2025-12-02

Biological Sample Repository for Gastrointestinal Disorders

Active not recruiting

500 enrolled

GastrointestinalOther

Collagen Diseases, Diabetes Mellitus, Diabetes Mellitus, Type 2, Digestive System Diseases, Gastroesophageal Reflux, Hyperlipidemias, Hypertension, Neoplasms, Obesity, Obesity, Morbid, Sleep Apnea Syndromes, Weight Loss, Overweight

NCT06782451 2025-09-29

DST

Phase NA Recruiting

50 enrolled

Tumor-Agnostic

Neoplasms

NCT07080333 2025-07-23

MICROBLADDERK

Phase NA Not yet recruiting

95 enrolled

Tumor-Agnostic

Neoplasms

NCT05655715 2024-10-16

CheckPRO

Phase 2 Completed

90 enrolled

Genitourinary

Neoplasms, Prostatic Neoplasms

NCT02595866 2024-08-09

Testing the Addition of an Experimental Medication MK-3475 (Pembrolizumab) to Usual Anti-Retroviral Medications in Patients With HIV and Cancer

Phase 1 Completed

58 enrolled 17 charts

DermatologicGastrointestinalLymphoidSarcomaThoracic

Carcinoma, Non-Small-Cell Lung, Carcinoma, Hepatocellular, Lung Neoplasms, Lymphoma, Non-Hodgkin, Melanoma, Neoplasm Metastasis, Neoplasms, Recurrence, Sarcoma, Kaposi, HIV Infections

NCT04994093 2024-06-26

Creating an Innovative AI-based Technology TCRact for Designing and Optimizing T-cell Receptors (TCR) for Use in Cancer Immunotherapies

Completed

118 enrolled

Gastrointestinal

Colonic Neoplasms, Neoplasms

NCT00250055 2024-03-12

Non-Invasive, Real-Time Technology for Diagnosis of Cervical Tissue

Phase NA Terminated

100 enrolled

Tumor-Agnostic

Neoplasms

NCT05763355 2024-02-28

BIOPROSTABORD

Phase NA Unknown

596 enrolled

Tumor-Agnostic

Neoplasms

NCT03333655 2022-08-12

Study to Explore the Mechanism of Acquired Immune Escape In Participants With Metastatic Cancer Progressing on CPI Therapy

Phase 4 Completed

15 enrolled

Tumor-Agnostic

Neoplasm Metastasis, Neoplasms

NCT04735445 2021-02-03

IMPACNEO

Phase NA Unknown

4,638 enrolled

Acquired Immunodeficiency Syndrome, Disease, Neoplasms

NCT04136470 2020-08-10

BioForte Technology for in Silico Identification of Candidates for a New Microbiome-based Therapeutics and Diagnostics

Unknown

130 enrolled

DermatologicThoracic

Carcinoma, Non-Small-Cell Lung, Melanoma, Neoplasms

NCT02613962 2020-02-17

MAPPYACTS

Phase NA Unknown

700 enrolled

Neoplasms, Recurrence

NCT02517281 2019-01-03

SKINTARGET

Phase NA Unknown

700 enrolled

Tumor-Agnostic

Neoplasms

NCT00433485 2016-09-23

Topical Sirolimus in Patients With Basal Cell Nevus Syndrome and in Healthy Participants

Phase 1 Completed

16 enrolled

Dermatologic

Basal Cell Nevus Syndrome, Carcinoma, Basal Cell, Neoplasms

NCT00900302 2016-02-10

OX-40 Protein Expression in the Sentinel Lymph Nodes of Patients With Cancer

Completed

98 enrolled

BreastDermatologicGastrointestinalGenitourinaryGynecologicHead & NeckThoracic

Squamous Cell Carcinoma of Head and Neck, Esophageal Squamous Cell Carcinoma, Anus Neoplasms, Urinary Bladder Neoplasms, Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Uterine Cervical Neoplasms, Esophageal Neoplasms, Gallbladder Neoplasms, Melanoma, Neoplasms, Neoplasms, Unknown Primary, Penile Neoplasms, Salivary Gland Neoplasms, Skin Neoplasms, Vulvar Neoplasms, Breast Neoplasms, Male

NCT00416390 2013-09-20

Lycopene in Treating Patients With Prostate Cancer or Benign Prostatic Hyperplasia

Phase NA Completed

120 enrolled

Genitourinary

Neoplasms, Prostatic Hyperplasia, Prostatic Neoplasms

NCT00865813 2009-03-19

Biopsy Incisional With Trepan in Periocular Lesions

Phase NA Unknown

40 enrolled

Tumor-Agnostic

Neoplasms

Clinical Trials

Novel Indenoisoquinolone CMYC/TOPOISOMERASE 1 Inhibitor (LMP744) in Recurrent Glioblastoma

NBI-CAB

NEPENTHE

Collection of Tissue Samples for Cancer Research

ELEPHAS-05

Biological Sample Repository for Gastrointestinal Disorders

DST

MICROBLADDERK

CheckPRO

Testing the Addition of an Experimental Medication MK-3475 (Pembrolizumab) to Usual Anti-Retroviral Medications in Patients With HIV and Cancer

Creating an Innovative AI-based Technology TCRact for Designing and Optimizing T-cell Receptors (TCR) for Use in Cancer Immunotherapies

Non-Invasive, Real-Time Technology for Diagnosis of Cervical Tissue

BIOPROSTABORD

Study to Explore the Mechanism of Acquired Immune Escape In Participants With Metastatic Cancer Progressing on CPI Therapy

IMPACNEO

BioForte Technology for in Silico Identification of Candidates for a New Microbiome-based Therapeutics and Diagnostics

MAPPYACTS

SKINTARGET

Topical Sirolimus in Patients With Basal Cell Nevus Syndrome and in Healthy Participants

OX-40 Protein Expression in the Sentinel Lymph Nodes of Patients With Cancer

Lycopene in Treating Patients With Prostate Cancer or Benign Prostatic Hyperplasia

Biopsy Incisional With Trepan in Periocular Lesions